Advertisement

Daily News

Most Recent

image: Triggering Resilience to Depression

Triggering Resilience to Depression

By | April 17, 2014

In mice, boosting depression-causing activity in neurons can actually reverse depressive symptoms.

4 Comments

image: A Face to Remember

A Face to Remember

By | April 17, 2014

Researchers show that a tuning algorithm can make one’s profile photo more memorable.

5 Comments

image: Trisomy 21 Effects Seen Genome-wide

Trisomy 21 Effects Seen Genome-wide

By | April 16, 2014

The extra chromosome behind Down’s syndrome can impact transcriptional regulation beyond chromosome 21, a study finds.

6 Comments

image: Traces of Trauma in Sperm RNA

Traces of Trauma in Sperm RNA

By | April 13, 2014

A mouse study shows that molecular remnants of early-life stress can be passed on to future generations.

2 Comments

image: Key Osmotic Channel Protein Identified

Key Osmotic Channel Protein Identified

By | April 10, 2014

A little-studied protein appears to be a critical part of the perplexing channel that prevents cells from bursting.

1 Comment

image: Amoeba Eats Cells Alive

Amoeba Eats Cells Alive

By | April 9, 2014

The intestinal parasite Entamoeba histolytica kills host cells by tearing pieces from them, which it then eats.

1 Comment

image: Obesity Complicates Colorectal Cancer

Obesity Complicates Colorectal Cancer

By | April 9, 2014

Study finds that prediagnosis obesity is predictive of poor prognosis, even among patients who have a molecular marker associated with better disease outcome.

1 Comment

People who report having enjoyed amphetamine are more likely to have gene variants associated with protection against attention deficit-hyperactivity disorder and schizophrenia, a study shows.

0 Comments

image: Telomeres Show Signs of Early-Life Stress

Telomeres Show Signs of Early-Life Stress

By | April 7, 2014

Reduction in telomere length is associated with stress early on in life and may have a genetic component, researchers find.

3 Comments

image: Epigenetic Cancer Therapy Clears Phase I

Epigenetic Cancer Therapy Clears Phase I

By | April 7, 2014

Investigational drug that inhibits proteins involved with epigenetic regulation shows activity against certain blood cancers in an early-stage clinical trial.

0 Comments

Follow The Scientist

icon-facebook icon-linkedin icon-twitter icon-vimeo icon-youtube
Advertisement

Stay Connected with The Scientist

  • icon-facebook The Scientist Magazine
  • icon-facebook The Scientist Careers
  • icon-facebook Neuroscience Research Techniques
  • icon-facebook Genetic Research Techniques
  • icon-facebook Cell Culture Techniques
  • icon-facebook Microbiology and Immunology
  • icon-facebook Cancer Research and Technology
  • icon-facebook Stem Cell and Regenerative Science
Advertisement
BioTek
BioTek
Advertisement
NeuroScientistNews
NeuroScientistNews